col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


46 Results       Page 1

 [1] 
Oxford University Press: The Journal of Applied Laboratory Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―14 Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay Dorsa Sohaei, Antigona Ulndreaj, Anu Mathew, Christopher Campbell, Martin Stengelin, George Sigal, et al. (+9)
2 [GO] 2022―Jul―20 Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era David I Bernstein, Asuncion Mejias, Barbara Rath, Christopher W Woods, Jamie Phillips Deeter
3 [GO] 2022―Jul―06 Fifteen-Month Follow-Up of Anti-Spike Receptor-Binding Domain SARS-CoV-2 Antibodies among Healthcare Workers in Boston, MA Maura C Dodge, Manisha Cole, Elizabeth R Duffy, Martha M Werler, Yachana Kataria
4 [GO] 2022―Jun―20 The Impact of COVID-19 on Laboratory Test Utilization at a Pediatric Medical Center David C Lin, Isaac Parakati, Shannon Haymond
5 [GO] 2022―Jun―20 Automated Library Construction and Analysis for High-throughput Nanopore Sequencing of SARS-CoV-2 Robin JN Coope, Nancy Matic, Pawan K Pandoh, Richard D Corbett, Duane E Smailus, Stephen Pleasance, et al. (+13)
6 [GO] 2022―Jun―20 Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations Across the United States in 2019 and Early 2020 David J Daghfal, Randal J Schneider, Phaedre Mohr, Edwin C Frias, John C Prostko, Lori J Sokoll
7 [GO] 2022―Jun―20 Observational Study of Receptor Binding Doman Spike Antibody Responses to Three SARS-CoV-2 Vaccinations in Non-Infected Subjects: Parallel Neutralizing Antibody and Cardiac Troponin I and T Observations Fred S. Apple, Bryan Bothwell, Jaya Koti, Westley Bauer, Robert Dwyer, Haode Chen, et al. (+6)
8 [GO] 2022―Jun―16 Is Measurement of Systemic IgG Antibodies the Wrong Way to Assess COVID-19 Vaccine Effectiveness for Breakthrough Infections? Stanley S Levinson
9 [GO] 2022―Jun―04 Manufacturer Signal-to-Cutoff Threshold Underestimates Cumulative Incidence of SARS-CoV-2 Infection: Evidence from the Los Angeles Firefighters Study Omar Toubat, Anders H. Berg, Kimia Sobhani, Karen Mulligan, Acacia M. Hori, Jay Bhattacharya, Neeraj Sood
10 [GO] 2021―Oct―11 Rate of Serum SARS-CoV-2 Antibody Decline for two mRNA Vaccines Alan H B Wu, Eric D Nguyen, Chui Mei Ong, Cassandra Yun, Kara L Lynch
11 [GO] 2021―Oct―08 Mixed experiences with commercial calibrators and controls for COVID-19 drugs Jens Martens-Lobenhoffer, Stefanie M Bode-Böger
12 [GO] 2021―Sep―07 Multiplatform assessment of saliva for SARS-CoV-2 molecular detection in symptomatic healthcare personnel and patients presenting to the emergency department Robert F Potter, Eric M Ransom, Meghan A Wallace, Caitlin Johnson, Jennie H Kwon, Hilary M Babcock, et al. (+4)
13 [GO] 2021―Jul―17 Comparison of Six SARS-CoV-2 Molecular Methods and Correlation with the Cycle Threshold Distribution in Clinical Specimens Saravanan Raju, Neil W Anderson, Elizabeth Robinson, Crystal Squires, Meghan A Wallace, Ray Zhang, et al. (+2)
14 [GO] 2021―Jul―01 Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19 Jean Amiral, Matthias H Busch, Sjoerd A M E G Timmermans, Chris P Reutelingsperger, Pieter van Paassen
15 [GO] 2021―Jun―30 Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 Eric J Nilles, Elizabeth W Karlson, Maia Norman, Tal Gilboa, Stephanie Fischinger, Caroline Atyeo, et al. (+11)
16 [GO] 2021―Jun―24 SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses Raymond T Suhandynata, Nicholas J Bevins, Jenny T Tran, Deli Huang, Melissa A Hoffman, Kyle Lund, et al. (+5)
17 [GO] 2021―Jun―23 Strategic Thinking in Test Selection for Mass SARS-CoV-2 Testing Sejal Morjaria, Rosa Nouvini, S Joseph Sirintrapun
18 [GO] 2021―Apr―06 Evaluation of the clinical performance of seven serological assays for SARS-CoV-2 for use in clinical laboratories Alexis Plaga, Ruhan Wei, Elizabeth Olson, Drew Payto, John Harrington, Pyik That Nwe-Kissig, et al. (+4)
19 [GO] 2021―Apr―05 How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned Jonathan M Tsai, Nicole V Tolan, Athena K Petrides, Sanjat Kanjilal, Manfred Brigl, Neal I Lindeman, et al. (+4)
20 [GO] 2021―Mar―22 Side-effects of COVID-19 on patient care: An INR story Lauren N Pearson, Stacy A Johnson, Dina N Greene, Allison B Chambliss, Christopher W Farnsworth, Deborah French, et al. (+7)
21 [GO] 2021―Mar―09 Serological Testing for COVID-19 Disease: Moving the Field of Serologic Surveillance Forward Abdulla A Damluji, Devin Rajan, Amanda Haymond, Christopher deFilippi
22 [GO] 2021―Feb―23 The Effects of “Dry Swab” Incubation on SARS-CoV-2 Molecular Testing Bijal A Parikh, Meghan A Wallace, Broc T McCune, Carey-Ann D Burnham, Neil W Anderson
23 [GO] 2021―Jan―18 Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19
24 [GO] 2020―Dec―08 Accuracy in measuring racial disparities during the COVID-19 pandemic needs improvement Aditi G M Patel, Chu J Hsiao, Henrietta O Fasanya, Michelle Stoffel, Martha E Lyon
25 [GO] 2020―Nov―26 COVID-19 Pandemic Planning: Simulation models to predict biochemistry test capacity for patient surges Martha E Lyon, Andrew Bajkov, Diane Haugrud, Barry D Kyle, Fang Wu, Andrew W Lyon
26 [GO] 2020―Nov―02 Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-pandemic and Pandemic Patient Populations Jianbo Yang, Edward C Pederson, Christopher Hamilton, Terri Neibauer, Kimberly Robyak, Pamela McGhee, et al. (+2)
27 [GO] 2020―Oct―28 Swab-free transport as an optimized pre-analytical workflow for SARS-COV-2 amplification Dina N Greene, Tawna Matthys, Christina M Lockwood
28 [GO] 2020―Oct―13 Analytic Sensitivity of Three Nucleic Acid Detection Assays in Diagnosis of SARS-CoV-2 Infection Jakob T Sieker, Coby Horowitz, Cheng-Tsung K Hu, Meriane Lacombe-Daphnis, Bernadette Chirokas, Coteia Pina, et al. (+5)
29 [GO] 2020―Sep―24 Comparison of two automated immunoassays for the detection of SARS-CoV-2 nucleocapsid antibodies Jacqueline A Hubbard, K Aaron Geno, Jenna Khan, Zbigniew M Szczepiorkowski, David de Gijsel, Anais A Ovalle, et al. (+7)
30 [GO] 2020―Aug―24 Heat inactivation of saliva samples for the analysis of cortisol and cortisone during the Covid-19 pandemic Joanne E Adaway, James M Hawley, Stephen J Lockhart, Brian G Keevil
31 [GO] 2020―Aug―10 SARS-CoV-2 Serology - Need for Quantitative Testing and Interpretive Reporting Stanley S Levinson
32 [GO] 2020―Aug―05 Multi-platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19 Raymond T Suhandynata, Melissa A Hoffman, Michael J Kelner, Ronald W McLawhon, Sharon L Reed, Robert L Fitzgerald
33 [GO] 2020―Aug―04 Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA Bryan Stevens, Catherine A Hogan, Malaya K Sahoo, ChunHong Huang, Natasha Garamani, James Zehnder, et al. (+2)
34 [GO] 2020―Jul―31 A COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies Lianna Goetz, Jianbo Yang, Wallace Greene, Yusheng Zhu
35 [GO] 2020―Jul―25 Evaluation of an electrochemiluminescent SARS-CoV-2 antibody assay C S Lau, S P Hoo, S F Yew, S K Ong, L T Lum, P Y Heng, et al. (+3)
36 [GO] 2020―Jul―13 Impact of COVID-19 Pandemic on Laboratory Utilization Thomas J S Durant, David R Peaper, David Ferguson, Wade L Schulz
37 [GO] 2020―Jul―01 An Initial Evaluation of the Agreement Between Two SARS-CoV-2 Serologic Assays Ariannette Y Robledo Gomez, Nichole R Hunt, Allison B Chambliss, Huy P Pham, Jane F Emerson, Maximo J Marin
38 [GO] 2020―Jun―30 Screening the general population for SARS CoV-2 virus and COVID-19 antibodies: a counter-argument Alan H B Wu
39 [GO] 2020―Jun―25 Out of the Darkness-Into the Light: Value of SARS-CoV-2 Antibody Testing in Populations to Benefit Public Health and in Individuals for Peace of Mind Robert H Christenson
40 [GO] 2020―Jun―25 What to expect from antibody assays of SARS-CoV-2? Xin Yi, Jing Cao
41 [GO] 2020―Jun―20 Laboratory tests and outcome for patients with COVID-19: A systematic review and meta-analysis Anne Alnor, Maria B Sandberg, Charlotte Gils, Pernille J Vinholt
42 [GO] 2020―Jun―01 Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA Caroline E Franks, Mitchell G Scott, Christopher W Farnsworth
43 [GO] 2020―May―29 Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene Jeffrey A SoRelle, Ithiel Frame, Alejandra Falcon, Jerin Jacob, Jennifer Wagenfuehr, Midori Mitui, et al. (+2)
44 [GO] 2020―Apr―28 Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory Dina N Greene
45 [GO] 2020―Apr―17 Contingency planning in the clinical laboratory: lessons learned amidst COVID-19 Allison B Chambliss, Nicole V Tolan
46 [GO] 2020―Apr―14 COVID-19 in Pediatrics: A Laboratory Perspective Jing Cao, Sridevi Devaraj
 [1] 

46 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.015 sec